Concepedia

Jeffrey Settleman

JS

123

Publications

32K

Citations

72

H-Index

1985

Active since

Affiliations

Harvard University(Current)

Massachusetts General Hospital

Center for Cancer Research

Dana-Farber Cancer Institute

Yale University

Jeffrey Settleman is an author at Harvard University specializing in medicine, cell biology, and cell signaling.

ORCID

Top concepts

Publications per year

1985–2023

123

Publications

123

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

Eunice L. Kwak, Yung‐Jue Bang, D. Ross Camidge et al. · New England Journal of Medicine · 2010 · 4.5K citations

Systematic identification of genomic markers of drug sensitivity in cancer cells

Mathew J. Garnett, Elena J. Edelman, Sonja J. Heidorn et al. · Nature · 2012 · 2.5K citations · Full text

, , +12

Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor <i>EML4-ALK</i>

Alice T. Shaw, Beow Y. Yeap, Mari Mino–Kenudson et al. · Journal of Clinical Oncology · 2009 · 1.9K citations · Full text

Detection of Mutations in <i>EGFR</i> in Circulating Lung-Cancer Cells

Shyamala Maheswaran, Lecia V. Sequist, Sunitha Nagrath et al. · New England Journal of Medicine · 2008 · 1.6K citations · Full text

Gefitinib-Sensitizing <i>EGFR</i> Mutations in Lung Cancer Activate Anti-Apoptotic Pathways

Raffaella Sordella, Daphne W. Bell, Daniel A. Haber et al. · Science · 2004 · 1.6K citations

Rows per page

1–5 of 123